Researchers at the University at Buffalo are beginning two new studies as part of an international effort to prevent type 1 diabetes. The project, called Type 1 Diabetes TrialNet, involves researchers at 22 clinical centers in the U.S. and in centers in Canada, Europe, Australia and New Zealand.